Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rankning i aktier #17188
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aktiekurs
$2.17
Marknadsvärde
$249.58M
Förändring (1 dag)
-1.67%
Förändring (1 år)
96.34%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Kategori

Aktiekurshistorik för Cardiol Therapeutics Inc. (CRDL)
Högsta slutkurs: $2.19 den 2026-09-01

Lägsta slutkurs: $3.27 den 2018-12-01
Aktiekurshistorik för Cardiol Therapeutics Inc. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 17.16%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$165.71 31.84%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.46 25.80%
CH